Several studies have examined the association between the genotype status of the most common CYP1A1 polymorphisms (Ile462Val, I462V, MspI, M4, and Thr461Asn) and the risk of ovarian cancer development [79,80,81,82,83]. This evidence concerns the gene CYP1A1 and ovarian cancer.